Status:
COMPLETED
Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study
Lead Sponsor:
Sanoculis Ltd
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
18-85 years
Brief Summary
This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trab...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female ≥ 18 years to ≤ 85 years old
- Subject who underwent MINT, and surgery was performed not earlier than 18 months from enrollment
Exclusion
Key Trial Info
Start Date :
November 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06612346
Start Date
November 4 2022
End Date
December 31 2024
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S. Malayan Eye Center
Yerevan, Armenia